For a licensed U.S. business buyer age 21 or older, the first brief should define what is being engineered, who controls each decision, and what evidence will prove the delivered hardware matches the agreed design. The OEM-versus-ODM choice follows from those boundaries; it should not replace them.
>
Begin With Manufacturing Responsibility, Not the Label
The phrase vape OEM manufacturer can describe very different engagements. One buyer may bring finished CAD files, a bill of materials, drawings, and test methods. Another may select and adapt an existing platform. Those are not equivalent starting points, even when both projects are called OEM.
Write the brief around responsibility. Identify the buying entity, product family, configuration code, and technical decision-maker. State who owns the design, electronics, firmware, component selection, artwork, and configuration release. “Buyer,” “manufacturer,” and “shared” are clearer than a promise to “customize.”
This matters because a component may affect performance. The federal definition of a tobacco-product component or part includes software or an assembly of materials intended or reasonably expected to affect performance or be used with human consumption; accessories are excluded. See 21 CFR Part 1100. FDA identifies cartridges, atomizers, certain batteries, displays, tanks, mouthpieces, and programmable software among regulated ENDS components and parts in its ENDS overview. Record design origin and deviation from the baseline.
OEM vs. ODM: Define the Design Boundary
The practical distinction is not whether a logo or color is changed. It is whether the buyer is supplying and controlling the product definition, or selecting from a manufacturer-originated platform with defined variation limits. Review the broader OEM, ODM, and private-label framework alongside the technical brief.
| Brief question | OEM-oriented answer | ODM-oriented answer |
|---|---|---|
| Where does the core design originate? | Buyer-controlled requirements, drawings, or engineering inputs. | Manufacturer-originated reference platform. |
| What must be frozen first? | Interfaces, materials, drawings, performance criteria, and revision level. | Base model, approved options, non-negotiable architecture, and configured SKU. |
| What is the main technical risk? | An incomplete or conflicting buyer specification. | Assumptions that an existing platform will behave like a bespoke design. |
| What proves alignment? | Build records and inspections against buyer-approved specifications. | A configuration matrix, baseline sample, and documented approved deviations. |
In an OEM program, attach or reference controlled source files: drawings, CAD revision, bill of materials, interfaces, and acceptance criteria. Classify any open requirement as a decision gate.
In an ODM program, assign the platform an identifier and revision. List permitted options—such as connection format, exterior treatment, indicator behavior, power configuration, or pack-out—and identify what cannot change. A modified configuration needs its own identifier so the sample, documents, and production configuration remain traceable.
Build a Brief That Engineering Can Quote
A quote-ready brief describes the object and its boundaries in enough detail that two qualified teams would interpret it the same way. Start with a configuration table rather than a marketing concept. Reference the applicable vapor-hardware product category only as a navigation point; the brief itself must identify the exact proposed assembly.
At minimum, define these fields:
- Configuration identity: project name, hardware type, revision, included and excluded items.
- Mechanical interfaces: connection, key dimensions, tolerances, seals, materials, and critical fits.
- Electrical and control system: power-source type, charging input, operating envelope, protection behavior, indicator states, and firmware identification where applicable.
- Functional performance: operating conditions, measurable outputs, test fixture, sequence, and pass/fail criteria—not “high performance” or “premium.”
- Manufacturing definition: buyer-controlled sources, assembly constraints, traceability expectation, and substitution approval.
- Commercial interface: quote structure, Incoterm if known, destination, forecast format, and import-coordination responsibility.
Use marked-up drawings, an exploded view, connector pinout, or state diagram for critical features. Give each figure a revision and date. Label provisional dimensions or materials, with an owner and release deadline.
FDA’s nonbinding ENDS PMTA guidance offers a useful discipline: precise product descriptions, component materials, operating ranges, power and charging information, schematics, engineering parameters, and electrical-safety discussion with supporting data as applicable. Read the FDA guidance. A technical brief is not a regulatory submission.
Set Validation, Quality, and Change Control Before Sampling
A sample is a checkpoint, not a substitute for the brief. Define its purpose—such as interface fit, electrical behavior, assembly assessment, or packaging fit—and state what it does not validate. Document findings with a controlled checklist, photographs, identifiers, and the exact configuration evaluated. Use the sample-evaluation checklist to structure the review.
Turn the brief into an acceptance plan. Specify critical-to-function characteristics—interfaces, seals, electrical protections, control behavior—and the evidence for each: inspection record, dimensional result, functional test, material declaration, or build traceability. Define workmanship and appearance with objective reference samples or images.
Require written change identification, the affected configuration, reason, risk assessment, verification, document updates, effective date, and buyer approval before implementation. Apply it to materials, electronic components, firmware, tooling, assembly, packaging, and sub-tier sources. The change-control checklist helps prevent undocumented “equivalent” substitutions.
Request Documentation and Confirm U.S. Relevance
Tie each documentation request to the configuration identifier and revision—not a generic company packet. Ask which assembly, material, firmware, pack-out, and date range it covers. Name an owner for questions and updates.
For proposed U.S. activity, verified business buyers should request product-specific regulatory status and applicable supporting documents from the responsible party. FDA regulates the manufacture, import, packaging, labeling, advertising, promotion, sale, and distribution of ENDS, including components and parts, while excluding accessories. See FDA’s manufacturer information. Do not assume a design label, sample, or supplier statement establishes a finished product’s status.
Import planning belongs in the first brief because product identification and import documentation should agree. CBP says the importing/exporting community shares responsibility for compliance and encourages businesses to understand laws and commodity-specific partner-agency requirements. CBP’s importing guidance is an official starting point. Confirm responsibilities with qualified advisors and responsible parties; this article is not legal advice.
FAQs
Is a logo-only change OEM or ODM?
A logo alone does not answer the question. Record the underlying platform, what changes, who approves the artwork and configuration, and whether the change affects any material, packaging, labeling, or technical file. In many cases, it is more precise to call it an ODM platform with defined branding changes.
When should a buyer freeze the technical brief?
Freeze the release before requesting a binding configuration-specific production quote or treating a sample as representative of the agreed product. Open decisions can remain in a decision log, but each needs an owner, a deadline, and an explicit impact on drawings, evidence, and commercial terms.
What is the minimum evidence to request with a sample?
Request the sample’s configuration and revision identifier, a parts or configuration list, observed test conditions, the applicable acceptance checklist, and a list of deviations from the intended release. The evidence should let another reviewer identify exactly what was evaluated.
Can one brief cover multiple configurations?
Yes, if it uses a master platform identifier plus a controlled variant matrix. Each variant should identify its permitted components, software or settings where relevant, artwork or pack-out differences, and unique acceptance points. Do not let different configurations share one label without a traceable distinction.
Sources and further reading
- FDA: E-Cigarettes, Vapes, and Other Electronic Nicotine Delivery Systems (ENDS) - eCFR: 21 CFR Part 1100—General - FDA: Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems - U.S. Customs and Border Protection: Basic Importing and Exporting
Ready to turn a product concept into a controlled B2B technical brief? Request a quote and include your configuration scope, drawings, acceptance criteria, and documentation questions.